Taghavi N, Biramijamal F, Sotoudeh M, Moaven O, Khademi H, Abbaszadegan MR, Malekzadeh R. Association of p53/p21 expression with cigarette smoking and prognosis in esophageal squamous cell carcinoma patients. World J Gastroenterol 2010; 16(39): 4958-4967 [PMID: 20954283 DOI: 10.3748/wjg.v16.i39.4958]
Corresponding Author of This Article
Firouzeh Biramijamal, PhD, Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology, Shahrak-e Pajoohesh, 17km, Tehran-Karaj High way, PO Box 14965/161, Tehran 14977-16316, Iran. f.birami@nigeb.ac.ir
Article-Type of This Article
Brief Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Noushin Taghavi, Firouzeh Biramijamal, Department of Medical Genetics, National Institute of Genetic Engineering and Biotechnology, Tehran 14977-16316, Iran
Masoud Sotoudeh, Hooman Khademi, Reza Malekzadeh, Digestive Disease Research Center, Tehran University of Medical Sciences, Shariati Hospital, North Karegar Ave, Tehran 14117-13135, Iran
Omeed Moaven, Mohammad Reza Abbaszadegan, Division of Human Genetics, Immunology Research Center, Avicenna Research Institute, Mashhad University of Medical Sciences, Mashhad 91967-73117, Iran
Author contributions: Taghavi N, Biramijamal F, Sotoudeh M and Malekzadeh R designed the research; Taghavi N performed the research; Taghavi N, Moaven O and Khademi H analyzed the data; Taghavi N and Moaven O wrote the paper; Biramijamal F, Abbaszadegan MR and Malekzadeh R scientifically edited the paper.
Supported by The National Institute of Genetic Engineering and Biotechnology, Projects No. 291, 316; and the Digestive Diseases Research Center of Tehran University of Medical Sciences
Correspondence to: Firouzeh Biramijamal, PhD, Department of Medical Genetics, National Institute for Genetic Engineering and Biotechnology, Shahrak-e Pajoohesh, 17km, Tehran-Karaj High way, PO Box 14965/161, Tehran 14977-16316, Iran. f.birami@nigeb.ac.ir
Telephone: +98-21-44580382 Fax: +98-21-44580399
Received: April 28, 2010 Revised: May 27, 2010 Accepted: June 3, 2010 Published online: October 21, 2010
Abstract
AIM: To investigate the expression of p53 and p21 and associations with possible risk factors, such as cigarette smoking, in esophageal squamous cell carcinoma (ESCC) in northeastern Iran, a region with a high incidence of ESCC.
METHODS: The expression of p53 and p21 proteins was investigated immunohistochemically in tumor tissue from 80 ESCC patients and in 60 available paraffin-embedded blocks of adjacent normal specimens from the cases, along with normal esophageal tissue from 80 healthy subjects.
RESULTS: Positive expression of p53 protein was detected in 56.2% (45/80) of ESCC cases, and in none of the normal esophageal tissue of the control group (P < 0.001). Furthermore, 73.8% (59/80) of ESCC cases and 43.8% (35/80) of controls had positive expression of p21 protein (P < 0.001). Cigarette smoking was significantly associated with p53 over-expression in ESCC cases (P = 0.010, OR = 3.64; 95% CI: 1.32-10.02). p21 over-expression was associated with poorer clinical outcome among the ESCC patients (P = 0.009).
CONCLUSION: Over-expression of p53 in association with cigarette smoking may play a critical role in ESCC carcinogenesis among this high-risk population of northeastern Iran. Furthermore, p21 over-expression was found to be associated with poor prognosis, specifically in the operable ESCC patients.
Taghavi N, Biramijamal F, Sotoudeh M, Moaven O, Khademi H, Abbaszadegan MR, Malekzadeh R. Association of p53/p21 expression with cigarette smoking and prognosis in esophageal squamous cell carcinoma patients. World J Gastroenterol 2010; 16(39): 4958-4967 [PMID: 20954283 DOI: 10.3748/wjg.v16.i39.4958]
